Nancy Richert

Author PubWeight™ 11.32^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Humanized anti-CD25 (daclizumab) inhibits disease activity in multiple sclerosis patients failing to respond to interferon beta.	Proc Natl Acad Sci U S A	2004	2.37
2	Effect of anti-CD25 antibody daclizumab in the inhibition of inflammation and stabilization of disease progression in multiple sclerosis.	Arch Neurol	2009	2.06
3	Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study.	Arch Neurol	2008	1.56
4	Regulatory T cells are reduced during anti-CD25 antibody treatment of multiple sclerosis.	Arch Neurol	2009	1.42
5	Lesions by tissue specific imaging characterize multiple sclerosis patients with more advanced disease.	Mult Scler	2011	0.85
6	CNS vasculitis in a patient with MS on daclizumab monotherapy.	Neurology	2013	0.81
7	Diffuse and focal corticospinal tract disease and its impact on patient disability in multiple sclerosis.	J Neuroimaging	2014	0.81
8	Treatment with the phosphodiesterase type-4 inhibitor rolipram fails to inhibit blood--brain barrier disruption in multiple sclerosis.	Mult Scler	2009	0.79
9	Comparison of methods for obtaining longitudinal whole-brain magnetization transfer measurements.	J Magn Reson Imaging	2002	0.76